Elon Musk bungles his criticism of U.S. drug regulators

This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox.

While barnstorming across Pennsylvania recently in support of Donald Trump’s presidential campaign, Elon Musk criticized the U.S. government for issuing too many rules and regulations. But in a twist on Musk’s familiar lament, he cited the FDA and a cancer drug called Welireg, not rockets, electric cars, or satellites. 

Earlier this year, the mother of a friend took Welireg in a clinical trial and it cured her brain cancer, Musk explained while on stage at a town hall meeting.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

Individual plans

Group plans

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$20

for 3 months, then $399/year

$20 for 3 months Get Started

Then $399/year

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe

Log In